Published: Wed, October 11, 2017
Money | By Armando Alvarado

Stock Noted in Oversold Range: Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens Boots Alliance, Inc. has 1.05 billion shares outstanding, and in the last trade has seen ATR around 1.61.

(NASDAQ:WBA) now has a beta of 1.24 making it more volatile than the market overall which by definition has a beta of 1. Analysts are forecasting earnings of $1.21 on a per share basis this quarter. Reilly Financial Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 7.9% in the 2nd quarter.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. State Street Corp lifted its holdings in Walgreens Boots Alliance by 1.8% during the first quarter. The price index is calculated by dividing the current share price by the share price ten months ago. Rhumbline Advisers grew its holdings in Walgreens Boots Alliance by 4.3% in the second quarter.

Moving average indicators are used widely for stock analysis. WBA is down around 0.82% from its 12-month high of $69.28 notched on Oct 10, 2017 but is -28.4% above its highest point the past 12 months of $89.69 a share. Finally, Sound Shore Management Inc.

Checking in on some valuation rankings, Walgreens Boots Alliance, Inc. Sound Shore Management Inc.

We can now take a quick look at some historical stock price index data. A ratio over one indicates an increase in share price over the period.

08/24/2017 - Loop Capital began new coverage on Walgreens Boots Alliance, Inc. giving the company a "buy" rating. The mean target price as estimated by the analysts for the company has been recorded at $93.00. The ROIC 5 year average of Walgreens Boots Alliance, Inc. Jefferies Group LLC reaffirmed a "buy" rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, October 2nd. Finally, Credit Suisse Group restated a "buy" rating and issued a $97.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the stock. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is now sitting at 21.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Tuesday, July 25th. A reading over 70 would indicate that the stock is overbought, and possibly overvalued. Following the transaction, the director now directly owns 19,151 shares of the company's stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & worldwide trademark and copyright laws. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & global trademark and copyright law.

Next Weeks Broker Price Targets For NGL ENERGY PARTNERS LP (NYSE:NGL)
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement.

WARNING: "Macguire Cheswick & Tuttle Investment Counsel LLC Reduces Position in Walgreens Boots Alliance, Inc". (NASDAQ:WBA) have caught the attention of investors.

The Leverage Ratio of Walgreens Boots Alliance, Inc.

When looking at companies that are considered to be oversold, it is important to consider the moving averages of the security.

Walgreens Boots Alliance announced that its board has authorized a stock repurchase plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in shares. There were 82 sold out positions, amounting to 5.13 million shares. Typically, the lower the value, the more undervalued the company tends to be. This represents a $1.60 annualized dividend and a dividend yield of 2.26%.

03/27/2017 - Walgreens Boots Alliance, Inc. had its "outperform" rating reiterated by analysts at Robert W. Baird. Kathleen Wilson-thompson has seen steady activity on the sell side, and on August 17, 2017, executed an option to sell 1825 shares. The Volatility 3m of Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc. The Firm is a pharmacy-led health and wellbeing company. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

A number of other large investors have also recently modified their holdings of the business.

Like this: